[Assessment of the genetic risk of radiation by irradiation data from laboratory mammals].
An attempt has been made to assess quantitatively genetic risk of radiation for man based on mammalian (mostly mouse) data and using the direct method proposed by UNSCEAR. The parameter employed was induction of reciprocal translocations. Two assumptions were made: human radiosensitivity equals that of the mouse; and dose-response is linear. From observations with acute gamma irradiation the estimate of risk per 10(-2) Gy was as follows: 39 translocation heterozygotes are expected among one million F1 conceptions, 5 cases of multiple congenital anomalies, 25 abortions recorded and 49 unrecorded. Chronic gamma irradiation at dose rates of 1.3 X 10(-5), 1.7 X 10(-4) and 1.0 X 10(-4) Gy/min was 3 to 10 times less effective. Exposure to 4.2 GeV deuterons proved inferior in effectiveness to gamma irradiation. Chronic exposure to 4.1 MeV neutrons delivered at 8 X 10(-4) Gy/min showed 7 times the effectiveness of chronic gamma irradiation. Administration of tritiated water (from 37 to 37 X 10(2) kBq/g b.w.) to rats entailed a risk of the same order of magnitude as external chronic gamma irradiation. Reduction of genetic risk was achieved by pretreatment with either AFT-, ATP-serotonin mixtures or the molecular combinations, Adeturon and Cytriphos. Study of interspecies differences in genetic radiosensitivity showed decline in the following order: rat-rabbit-mouse-Syrian hamster. A dose-rate effect was most clearly seen in the rat, and least clearly in the rabbit. In female mice, examination of oocyte depletion indicated primary follicles to be highly susceptible to acute gamma irradiation; decrease in sensitivity was observed beginning with stage 4. Chronic gamma irradiation was found to be less effective.
D000255:Adenosine Triphosphate; D000818:Animals; D000830:Animals, Laboratory / Q000235:genetics*; D006224:Cricetinae; D003543:Cysteamine; D003903:Deuterium; D004307:Dose-Response Relationship, Radiation; D004338:Drug Combinations; D005260:Female; D005720:Gamma Rays; D006801:Humans; D008297:Male; D008647:Mesocricetus; D051379:Mice; D009502:Neutrons; D009865:Oocytes / Q000528:radiation effects; D011817:Rabbits; D011833:Radiation Injuries, Experimental / Q000453:epidemiology* / Q000517:prevention & control; D011836:Radiation Tolerance; D011837:Radiation-Protective Agents / Q000008:administration & dosage; D051381:Rats; D012306:Risk; D013045:Species Specificity; D013090:Spermatocytes / Q000528:radiation effects; D014178:Translocation, Genetic / Q000528:radiation effects
D004338:Drug Combinations; D011837:Radiation-Protective Agents; C045755:adenosine triphosphate, cysteamine drug combination; D003543:Cysteamine; D000255:Adenosine Triphosphate; D003903:Deuterium
Otsenka geneticheskogo riska radiatsii po dannym oblucheniia u laboratornykh mlekopitaiushchikh.